/https%3A%2F%2Fmedia.npr.org%2Fassets%2Fimg%2F2024%2F05%2F15%2Fthroughline_tile-art_sq-a59d7da2ea2bf97562aeec6440ddf837e8f7de65.jpg%3Fs%3D1400%26c%3D66%26f%3Djpg)
Throughline
NPR
The dramatic race to discover Insulin
OCT 22, 202637 MIN
/https%3A%2F%2Fnpr.brightspotcdn.com%2Fdims3%2Fdefault%2Fstrip%2Ffalse%2Fcrop%2F4970x4970%2B0%2B0%2Fresize%2F3000%2Fquality%2F66%2Fformat%2Fjpg%2F%3Furl%3Dhttp%253A%252F%252Fnpr-brightspot.s3.amazonaws.com%252Ffd%252F78%252Fc52487db40188bbe5c7b3c988848%252F9d3ebf18-8ca2-4f49-b2a8-c589b344ae0c.jpeg)
Description
Looksmaxxing, weight loss, and muscle building have fueled a massive craze for injectable peptides. Some natural and some synthetic. These injectables have unleashed a multi-billion-dollar gray-market industry online and a high-stakes frontier for the pharmaceutical industry. Today, we reach back to the quest to manufacture the first peptide-based medicine: Insulin.
Guests:
Alison Li, historian of science and medicine, author of J. B. Collip and the Development of Medical Research in Canada: Extracts and Enterprise
Grant Maltman, curator of Banting House National Historic Site
Support public media with NPR+ and enjoy perks for over 25 podcasts like this one. This show’s perks include sponsor-free listening. Learn more at plus.npr.org.
See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.
NPR Privacy Policy

